|
|
|
|
|
|
|
|
|
|
|
|
|
05.02.26 - 15:15
|
Omnicell (OMCL) Q4 Earnings Lag Estimates (Zacks)
|
|
|
Omnicell (OMCL) delivered earnings and revenue surprises of -15.34% and +0.14%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
|
|
|
|
|
05.02.26 - 12:33
|
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results (Business Wire)
|
|
|
Omnicell delivers solid fourth quarter 2025 financial results
Announces major step toward autonomous medication management with the launch of its next generation dispensing system, Titan XT, at the American Society of Health-System Pharmacists (ASHP) 2025 Midyear Clinical Meeting & ExhibitionFORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, today announced results for its fiscal year and fourth quarter ended December 31, 2025.
“We finished 2025 with solid fourth quarter financial results, delivering full year 2025 total revenues, product bookings and annual recurring revenues ('ARR') all above the mid-point of our previously issued guidance ranges,” stated Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “As we look ahead, we are focused on delivering long-term, s...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.01.26 - 14:03
|
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 (Business Wire)
|
|
|
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the fourth quarter and full year 2025, before market open on Thursday, February 5, 2026. The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m. ET that same day.
All interested parties are invited to listen to the live call and presentation by dialing (800) 715-9871 in the U.S. or (646) 307-1963 in international locations. The Conference ID is 4203777.
A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell's website at https://ir.omnicell.com/events-and-presentations/.
About Omnicell
Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, Omnicell empowers autonomous me...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
